BuybackJun 8, 2026, 08:06 AM
BioNTech Commences $1.0B Share Buyback Program
AI Summary
BioNTech SE announced the commencement of its previously authorized share repurchase program. The company plans to buy back up to $1.0 billion in American Depositary Shares (ADSs) on the U.S. Nasdaq Global Select Market. The buyback period begins on June 8, 2026, and will run until May 6, 2027, aiming to enhance capital efficiency and maintain financial flexibility.
Key Highlights
- BioNTech commences $1.0 billion share repurchase program for ADSs.
- The buyback period starts June 8, 2026, and concludes May 6, 2027.
- Repurchases will occur on the U.S. Nasdaq Global Select Market.
- Program aims to satisfy obligations, enhance capital efficiency, and maintain financial flexibility.
- Authorized by AGM on May 17, 2024, allowing up to 10% of share capital.
- Maximum 24.9 million shares can be repurchased under AGM authorization.
- The buyback will be lead-managed by an independent credit institution.
- Transactions will be disclosed on BioNTech's website.
Price Impact
More from BNTX